Palverafusp alfa
Based on 1 Customer Validation
Palverafusp alfa (IMM-2510; SYN-2510) is a PD-L1/VEGF-targeting IgG1κ type humanized antibody. Palverafusp alfa blocks PD-1/PD-L1 binding, relieves immune suppression, mediates PD-L1-directed antibody-dependent cellular cytotoxicity (ADCC). Palverafusp alfa blocks VEGF/VEGFR binding, inhibits angiogenic signaling, relieves VEGF-induced immune suppression. Palverafusp alfa reduces endothelial cell proliferation, enhances ADCC and antibody-dependent cellular phagocytosis (ADCP), inhibits tumor growth, reverses T cell immune suppression. Palverafusp alfa exhibits immune stimulatory, antiangiogenic, and anti-tumor activity in the tumor microenvironment. Palverafusp alfa can be used for the research of cancer, such as solid tumors, non-small cell lung cancer.
For research use only. We do not sell to patients.
- Purity : 98.00%
- CAS No.: 2850355-87-0
- Molecular Weight:169.11 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All VEGFR Isoforms
More
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
VEGFA/PD-L1[1]
In Vitro
Palverafusp alfa binds to PD-L1-expressing cell lines and human PBMCs, blocks PD-L1/PD-1 ligand-receptor interactions, and exhibits cooperative binding[1].
Palverafusp alfa inhibits VEGF/VEGFR signaling and reduces HUVEC proliferation to block angiogenesis[1].
Palverafusp alfa functionally inhibits T cell immune suppression in Jurkat-PD-1 reporter assays with Raji-PD-L1 cells, with VEGF-enhanced anti-PD-L1 function[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
- Multiplex immunofluorescence IHC
- Mammalian live/dead viability and cytotoxicity staining
- BrdU Incorporation Assay
- Somatic Cell Culture
- CFSE Dye Dilution Proliferation Assay
- Multiplex immunohistochemistry
- Dye-dilution cell tracking and proliferation staining
- Patient-Derived Orthotopic Xenograft (PDOX)
- CCK-8/WST-8 Cell Proliferation Assay
- Protocol for Cell Cycle
- Cell Counting-Based Growth Curve Assay
- Colony Formation (Clonogenic) Assay
- Research Protocol for Cancer Immunology
- Cell Viability Determination by MTT Colorimetric Assay
- Phagocytosis Functional Assay
- EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
- Ki-67 Immunostaining Proliferation Assay
- Cell Cytotoxicity Assay
- PCNA Immunodetection Proliferation Assay
- Protocol for Cell Counting and Cell Density Analysis
- Patient-Derived Xenograft (PDX)
- MTT Cell Proliferation Assay
- Subcutaneous Cell-Line-Derived Xenograft
- Orthotopic Cell-Line Xenograft
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa-[PROTEIN]2-in-VH
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Loaded Palverafusp alfa on AHC2 biosensor, can bind VEGF121 Protein, Human (HEK293, His, HY-P70519) with an affinity constant of 2.310E-10 M as determined in BLI assay.
Chemical Information
-
CAS No. 2850355-87-0
-
Appearance Liquid
-
Molecular Weight 169.11 kDa
-
Color Colorless to light yellow
-
SMILES
[Palverafusp alfa]
-
Synonyms
IMM-2510; SYN-2510
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)